As one CoverMyMeds leader aptly put it, when ePA is designed to fit the prescribers workflow, it offers undeniable advantages to patients ( [75] )
C.C: compound C, EX-4: exendin-4, GLUT3: glucose transporter 3, PGC-1: peroxisome proliferator-activated receptor coactivator 1
Endocr Rev (2012) 33(4):595622.10.1210/er.2011-1044 62 ShahMVellaA
[8] [9] Common Gastrointestinal Side Effects Explained Nausea, diarrhoea, vomiting, and constipation are the most common gastrointestinal side effects of retatrutide, reported in up to 60% of Phase 2 trial participants and increasing with higher doses
It enhances cell migration, promotes tissue regeneration, and improves flexibility
Both vial and pen formulations should never be frozen, as ice crystal formation can damage the medication's molecular structure and render it ineffective